Cutler Group LP Crispr Therapeutics Ag Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 07, 2023	SELL	$39.19 - $65.67 $43,109 - $72,237	-1,100 Reduced 5.58%	18,600 $0
Q3 2022 Oct 25, 2022	SELL	$61.1 - $83.78 $531,570 - $728,886	-8,700 Reduced 30.63%	19,700 $12,000
Q2 2022 Aug 04, 2022	BUY	$43.23 - $73.83 $285,318 - $487,278	6,600 Added 30.28%	28,400 $41,000
Q1 2022 Apr 14, 2022	SELL	$53.19 - $79.24 $1.36 Million - $2.02 Million	-25,500 Reduced 53.91%	21,800 $22,000
Q4 2021 Jan 18, 2022	BUY	$70.09 - $111.29 $1.79 Million - $2.85 Million	25,600 Added 117.97%	47,300 $87,000
Q3 2021 Oct 26, 2021	SELL	$110.2 - $156.64 $143,260 - $203,631	-1,300 Reduced 5.65%	21,700 $199,000
Q2 2021 Jul 19, 2021	SELL	$100.84 - $161.89 $635,292 - $1.02 Million	-6,300 Reduced 21.5%	23,000 $721,000
Q1 2021 Apr 26, 2021	BUY	$110.72 - $210.04 $1.8 Million - $3.42 Million	16,300 Added 125.38%	29,300 $521,000
Q4 2020 Jan 21, 2021	BUY	$79.67 - $173.23 $772,799 - $1.68 Million	9,700 Added 293.94%	13,000 $695,000
Q3 2020 Oct 27, 2020	SELL	$78.5 - $100.64 $863,500 - $1.11 Million	-11,000 Reduced 76.92%	3,300 $31,000
Q2 2020 Jul 22, 2020	BUY	$38.5 - $76.05 $504,350 - $996,255	13,100 Added 1091.67%	14,300 $135,000
Q1 2020 May 07, 2020	BUY	$33.68 - $62.53 $30,312 - $56,277	900 Added 300.0%	1,200 $2,000
Q4 2019 Feb 06, 2020	SELL	$36.68 - $73.13 $7,336 - $14,626	-200 Reduced 40.0%	300 $3,000
Q4 2018 Feb 05, 2019	SELL	$22.73 - $42.34 $81,828 - $152,424	-3,600 Reduced 87.8%	500 $0
Q3 2018 Nov 07, 2018	SELL	$44.35 - $65.71 $554,375 - $821,374	-12,500 Reduced 75.3%	4,100 $11,000
Q2 2018 Aug 10, 2018	BUY	$42.62 - $73.59 $566,846 - $978,747	13,300 Added 403.03%	16,600 $149,000
Q1 2018 May 11, 2018	BUY	$23.52 - $58.17 $9,408 - $23,268	400 Added 13.79%	3,300 $38,000
Q4 2017 Jan 17, 2018	SELL	$16.95 - $23.48 $476,295 - $659,788	-28,100 Reduced 90.65%	2,900 $12,000
Q3 2017 Oct 17, 2017	BUY	$16.75 - $20.66 $519,250 - $640,460	31,000	31,000 $27,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$367 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$347 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$139 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$137 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$137 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account